Related Experiment Video
Updated: Jul 7, 2025

09:14
Establishment of a Novel Ex Vivo Lung Perfusion System for Rat Lungs After Circulatory Death
Published on: October 18, 2024
440
[Development of extracorporeal circulation in China]
1Department of Extracorporeal Circulation and Mechanical Circulation Assistants, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China.
Zhonghua Yi Xue Za Zhi
|December 21, 2023
Summary
Extracorporeal circulation (ECC) in China has matured over 65 years, improving cardiovascular surgery success rates. Derived extracorporeal membrane oxygenation (ECMO) also advanced critical care, with future focus on precision medicine.
Area of Science:
- Cardiovascular Surgery
- Critical Care Medicine
- Medical Technology Development
Context:
- Extracorporeal circulation (ECC) development in China spans 65 years since 1958.
- ECC has progressed through distinct phases: exploration, growth, maturity, and advanced development.
- Cardiovascular surgery utilizing ECC is now widely implemented nationwide, demonstrating enhanced success rates.
Purpose:
- To review the historical development and current status of extracorporeal circulation (ECC) in China.
- To highlight the advancements in cardiovascular surgery and critical care, including extracorporeal membrane oxygenation (ECMO).
- To outline future directions for ECC in China, emphasizing professional standardization and precision treatment.
Summary:
- Extracorporeal circulation (ECC) in China has evolved significantly over 65 years, establishing itself as a mature technology.
- The application of ECC has led to increased success rates in cardiovascular surgeries across the country.
- Extracorporeal membrane oxygenation (ECMO), a derivative of ECC, has seen substantial growth in critical care applications.
Impact:
- ECC has substantially improved outcomes for cardiovascular surgery in China.
- The development of ECMO has enhanced capabilities in managing critically ill patients.
- Future advancements in ECC, guided by precision medicine, are expected to further benefit national health outcomes.

